Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionCornerstone Wealth Management, LLC
Latest Disclosed Ownership7,332 shares
Latest Disclosed Value $ 1,021,792
Cornerstone Wealth Management, LLC reports 3.35% increase in ownership of GILD / Gilead Sciences, Inc.

On April 23, 2026 - Cornerstone Wealth Management, LLC filed a 13F-HR form disclosing ownership of 7,332 shares of Gilead Sciences, Inc. (CH:GILD) valued at $1,021,792 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 7,094 shares of Gilead Sciences, Inc.. This represents a change in shares of 3.35% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-23 2026-03-31 13F GILEAD SCIENCES COM 375558103 7,332 238 3.35 1,022 17.36 0.0511
2026-02-05 2025-12-31 13F GILEAD SCIENCES COM 375558103 7,094 -385 -5.15 871 4.82 0.0453
2025-11-04 2025-09-30 13F GILEAD SCIENCES COM 375558103 7,479 113 1.53 830 1.72 0.0458
2025-08-12 2025-06-30 13F GILEAD SCIENCES COM 375558103 7,366 10 0.14 817 -0.97 0.0496
2025-04-18 2025-03-31 13F GILEAD SCIENCES COM 375558103 7,356 -308 -4.02 824 16.55 0.0558
2025-01-21 2024-12-31 13F GILEAD SCIENCES COM 375558103 7,664 15 0.20 708 10.30 0.0478
2024-10-16 2024-09-30 13F GILEAD SCIENCES COM 375558103 7,649 -190 -2.42 641 19.37 0.0451
2024-07-16 2024-06-30 13F GILEAD SCIENCES COM 375558103 7,839 -185 -2.31 538 -8.52 0.0414
2024-04-19 2024-03-31 13F GILEAD SCIENCES COM 375558103 8,024 -415 -4.92 588 -14.06 0.0476
2024-01-10 2023-12-31 13F GILEAD SCIENCES COM 375558103 8,439 -574 -6.37 684 1.19 0.0588
2023-11-07 2023-09-30 13F GILEAD SCIENCES COM 375558103 9,013 373 4.32 676 1.50 0.0638
2023-07-14 2023-06-30 13F GILEAD SCIENCES COM 375558103 8,640 344 4.15 666 -3.34 0.0595
2023-05-15 2023-03-31 13F GILEAD SCIENCES COM 375558103 8,296 -174 -2.05 688 31.55 0.0676
2022-10-14 2022-09-30 13F GILEAD SCIENCES COM 375558103 8,470 38 0.45 523 0.38 0.0582
2022-08-04 2022-06-30 13F GILEAD SCIENCES COM 375558103 8,432 285 3.50 521 7.64 0.0578
2022-04-21 2022-03-31 13F GILEAD SCIENCES COM 375558103 8,147 -713 -8.05 484 -23.90 0.0470
2022-02-14 2021-12-31 13F GILEAD SCIENCES COM 375558103 8,860 29 0.33 636 3.08 0.0606
2021-11-12 2021-09-30 13F GILEAD SCIENCES COM 375558103 8,831 -649 -6.85 617 -5.51 0.0656
2021-08-09 2021-06-30 13F GILEAD SCIENCES COM 375558103 9,480 539 6.03 653 12.98 0.0687
2021-04-30 2021-03-31 13F GILEAD SCIENCES COM 375558103 8,941 1,703 23.53 578 36.97 0.0684
2021-01-29 2020-12-31 13F GILEAD SCIENCES COM 375558103 7,238 404 5.91 422 -2.31 0.0530
2020-10-13 2020-09-30 13F GILEAD SCIENCES COM 375558103 6,834 -701 -9.30 432 -25.52 0.0640
2020-07-16 2020-06-30 13F GILEAD SCIENCES COM 375558103 7,535 341 4.74 580 7.81 0.0938
2020-05-13 2020-03-31 13F GILEAD SCIENCES COM 375558103 7,194 2,883 66.88 538 92.14 0.1037
2020-02-20 2019-12-31 13F GILEAD SCIENCES COM 375558103 4,311 -651 -13.12 280 -10.83 0.0454
2019-10-28 2019-09-30 13F GILEAD SCIENCES COM 375558103 4,962 174 3.63 314 -3.09 0.0554
2019-08-02 2019-06-30 13F GILEAD SCIENCES COM 375558103 4,788 448 10.32 324 -70.89 0.0582
2019-05-13 2019-03-31 13F GILEAD SCIENCES COM 375558103 4,340 -77 -1.74 1,113 304.73 0.1352
2019-02-13 2018-12-31 13F GILEAD SCIENCES COM 375558103 4,417 -408,385 -98.93 275 -94.54 0.0587
2018-10-19 2018-09-30 13F GILEAD SCIENCES COM 375558103 412,802 48,753 13.39 5,035 -1.43 0.0634
2018-07-20 2018-06-30 13F GILEAD SCIENCES COM 375558103 364,049 359,060 7,197.03 5,108 1,311.05 0.0576
2018-04-24 2018-03-31 13F GILEAD SCIENCES COM 375558103 4,989 -599 -10.72 362 -11.92 0.0691
2018-02-09 2017-12-31 13F GILEAD SCIENCES COM 375558103 5,588 553 10.98 411 -0.48 0.0771
2017-11-14 2017-09-30 13F GILEAD SCIENCES COM 375558103 5,035 -42 -0.83 413 18.34 0.0856
2017-08-11 2017-06-30 13F GILEAD SCIENCES COM 375558103 5,077 814 19.09 349 22.89 0.0783
2017-05-11 2017-03-31 13F GILEAD SCIENCES COM 375558103 4,263 1,037 32.15 284 19.33 0.0702
2017-02-14 2016-12-31 13F GILEAD SCIENCES COM 375558103 3,226 549 20.51 238 14.98 0.0763
2016-10-31 2016-09-30 13F GILEAD SCIENCES COM 375558103 2,677 2,677 207 0.0764
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.